LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026

Rhea-AI Summary

LENSAR (Nasdaq: LNSR) will release its second quarter 2026 financial results before the market opens on Thursday, August 13, 2026. Management will hold a conference call and webcast at 8:30 a.m. ET the same day to discuss results, recent developments, and strategic initiatives.

Market Context

The prior comparable earnings-date notice produced -2.97% over 24 hours, adding a negative historica...

Analysis

The prior comparable earnings-date notice produced -2.97% over 24 hours, adding a negative historical reference to this scheduling update. The announcement contains no reported results, leaving the upcoming disclosure as the central information risk.

Key Figures

Reporting period: Second quarter 2026 Results release date: August 13, 2026 Conference call time: 8:30 am ET

3 metrics

Reporting period Second quarter 2026 Financial results announcement

Results release date August 13, 2026 Before market open

Conference call time 8:30 am ET August 13, 2026

Previous Earnings date Reports

1 past event · Latest: Apr 30 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 30	earnings date	Neutral	-3.0%	Prior first-quarter results scheduling announcement preceded a negative 24-hour price reaction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The prior tag-matched earnings-date announcement was followed by a negative 24-hour reaction, contrasting with LNSR’s positive pre-publication move.

Key Terms

astigmatism, dual-modality laser

2 terms

astigmatism medical

"treatment of cataracts and the management of astigmatism"

Astigmatism is a common vision condition in which the eye’s focusing surfaces are unevenly curved, causing light to land at multiple points and producing blurred or distorted vision at near and far distances; imagine a football instead of a perfectly round ball that doesn’t focus or roll uniformly. It matters to investors because how common and progressive the condition is drives steady demand for corrective products, surgeries and diagnostic equipment, influencing sales, market size and growth prospects for eye‑care companies.

dual-modality laser technical

"utilizing an extremely fast dual-modality laser"

A dual-modality laser is a medical or industrial laser system that can operate in two different modes or wavelengths, allowing it to perform distinct types of procedures or target different tissue depths and materials with the same device. Like a multi-tool that switches between a knife and a screwdriver, it lets users treat a broader range of conditions or applications with one instrument, which matters to investors because it can expand a product’s market, improve device utilization, and affect regulatory, manufacturing and reimbursement dynamics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ORLANDO, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s second quarter 2026 financial results will be released before market open on Thursday, August 13, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, August 13, 2026 to discuss the results, recent corporate and operational highlights and provide an update on key strategic initiatives.

To participate by telephone, please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call. The live webcast can be accessed under “Events & Presentations” in the Investor Relations section of the company’s website at https://ir.lensar.com. Following the live webcast, an archived version of the call will be available on the website.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline^® software technology, designed to guide surgeons to achieve better outcomes.

Contacts:		Lee Roth
Mike Rossi, Interim CFO		Burns McClellan for LENSAR
ir.contact@lensar.com		lroth@burnsmc.com

FAQ

When will LENSAR (NASDAQ: LNSR) report its Q2 2026 earnings results?

LENSAR will report its second quarter 2026 financial results on Thursday, August 13, 2026, before the market opens. According to LENSAR, the release will precede an earnings conference call that morning.

What time is LENSAR's Q2 2026 earnings conference call on August 13, 2026?

LENSAR’s Q2 2026 earnings conference call is scheduled for 8:30 a.m. ET on August 13, 2026. According to LENSAR, management will discuss results, corporate highlights, and key strategic initiatives.

How can investors access the LENSAR (LNSR) Q2 2026 earnings webcast?

Investors can access LENSAR’s live Q2 2026 webcast under the “Events & Presentations” section of the Investor Relations page at https://ir.lensar.com. According to LENSAR, an archived version will be available after the call.

How do I register to join LENSAR's Q2 2026 earnings call by telephone?

To join by telephone, participants must use LENSAR’s provided registration link and complete online registration in advance. According to LENSAR, all callers are required to register before accessing the conference call.

What topics will LENSAR management cover on the Q2 2026 LNSR earnings call?

LENSAR management plans to discuss Q2 2026 financial results, recent corporate and operational highlights, and key strategic initiatives. According to LENSAR, these topics will be addressed during the August 13, 2026 conference call and webcast.